ProNAi Therapeutics Lands $310,000 New Round

  • Feed Type
  • Date
    4/4/2012
  • Company Name
    ProNAi Therapeutics
  • Mailing Address
    2725 South Industrial Hwy Ann Arbor, MI 48104
  • Company Description
    ProNAi Therapeutics, Inc. is an emerging biopharmaceutical company that is leveraging its novel and proprietary nucleic acid-based interfering technology, DNAi, to advance a next generation of therapies for patients with cancer and other complex genetic diseases.
  • Website
    http://www.pronai.com
  • Transaction Type
    Debt
  • Transaction Amount
    $310,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.